B · Normal
[Late-stage trial reaches primary endpoint, Eli Lilly plans to expand Omvoh indication for treatment of ulcerative colitis in children] On October 20, Eli Lilly announced that after the success of a late-stage trial of Omvoh injection in children with ulcerative colitis, the company plans to seek to expand the indication for this intestinal disease treatment. The safety profile of Omvoh in this study was consistent with the drug's established tolerability profile in adult patients.
medicine 🕐 2026-10-20 15:00
#medicine
Save as Image Generate a beautiful long image to share on Moments or in group chats Generate now ⬇
← Back to Telegraph

Related telegraphs

[The State Food and Drug Administration held a "Artificial Intelligence + Drug S 10-20 16:29 On October 19th, Merck Group planned to acquire Silence Therapeutics for US$20 p 10-19 20:02 On October 19th, Eli Lilly announced that its drug Omvoh achieved the primary en 10-19 16:42 [AI and price increases are two-wheel drive, more than 130 A-share companies hav 10-19 06:14 [The 11th "Selenium Expo" was held in Enshi, Hubei] On October 18, the 11th Worl 10-18 15:15 On October 16th, Eli Lilly said that its oral weight loss drug Foundayo has been 10-16 18:01

Comments

0/500
Captcha (click to refresh)
No comments yet